Transcription Factor Induction of Germ Cells
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for inducing primordial germ cell-like cells (PGCLCs) from epiblast-like cells rely on cytokines, which are costly and inefficient, and the precise mechanism of germ cell fate induction by transcription factors remains unclear.
Innovation Solution
The method involves the forced expression of exogenous transcription factors Blimp1, Prdm14, and Tfap2c in epiblast-like cells to induce a PGCLC state without cytokines, using piggyBac transposon-based vectors and tetracycline regulatory elements, allowing for conditional expression and reconstitution of the germ cell lineage.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If cytokines (BMP4, LIF, SCF, BMP8b, EGF) are used to induce PGCLCs from EpiLCs, then the germ cell lineage can be generated, but the method becomes costly and inefficient
Solution Approach 1:
The patent extracts and replaces the costly cytokine-based induction system with a transcription factor-based system. Specifically, it uses exogenous transcription factors (Blimp1, Prdm14, Tfap2c) expressed via piggyBac transposon-based vectors to induce PGCLC differentiation, eliminating the need for expensive cytokines (BMP4, LIF, SCF, BMP8b, EGF) while maintaining or improving induction efficiency
Solution Approach 2:
The patent changes the fundamental parameter of induction mechanism from cytokine signaling to transcription factor expression. By using tetracycline-regulated expression systems and piggyBac vectors, it achieves precise control over transcription factor timing and dosage, resulting in more efficient and cost-effective PGCLC generation
2Ease of manufacture
If forced expression of exogenous transcription factors is used to induce germ cell fate, then the mechanism becomes clearer and costs are reduced, but the precise mechanism of action of key TFs remains unknown
Solution Approach 1:
The patent segments the transcription factor induction system into modular components: piggyBac transposon-based vectors for delivery, tetracycline-regulated expression systems for control, and specific TF combinations (Blimp1, Prdm14, Tfap2c) for functional analysis. This segmentation enables systematic investigation of individual TF mechanisms while maintaining overall system simplicity
Solution Approach 2:
The patent uses tetracycline as an intermediary substance to control transcription factor expression. The tetracycline-regulated system acts as a mediator between external control and internal TF expression, allowing precise temporal and dosage control to elucidate mechanism of action while keeping the induction method simple
3Adaptability or versatility
If piggyBac transposon-based vectors with tetracycline regulatory elements are used, then conditional expression is achieved, but the system complexity increases
Solution Approach 1:
The patent employs piggyBac transposon-based vectors that serve multiple functions: they deliver transcription factors, enable conditional expression through tetracycline regulation, and allow for precise temporal control of TF expression. This multi-functionality achieves adaptability without proportionally increasing complexity
Data Source
AI summary
This invention provides a method of producing a primordial germ cell-like cell (PGCLC) from an epiblast isolated from an embryo or an epiblast-like cell (EpiLC) induced from a pluripotent stem cell (PSC), which comprises allowing the epiblast or EpiLC to express exogenous transcription factor(s) selected from the group consisting of: (i) Blimp1, Prdm14 and Tfap2c; ii) Blimp1 and Prdm14; (iii) Blimp1 and Tfap2c; (iv) Prdm14 and Tfap2c; and (v) Prdm14; thereby inducing the epiblast or EpiLC into a PGC state without acquiring transient mesodermal program.